October 27, 2009 07:31 AM Eastern Time

BUSINESS WIRE

PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056

The following chart depicts the mean aPTT observed during the study (Graphic: Business Wire)

The following chart depicts the mean aPTT observed during the study (Graphic: Business Wire)

Opens in new window

Download

Thumbnail JPEG, 72x47, 35.4 KB
Preview JPEG, 144x95, 46.8 KB
Small JPEG, 300x197, 78.5 KB
Full Size JPEG, 1428x938, 643.0 KB

Smart Multimedia Gallery

The following charts depict the mean blood pressures observed during the study (Graphic: Business Wire)

The following charts depict the mean blood pressures observed during the study (Graphic: Business Wire)

View and Share Graphic

The following chart depicts the mean aPTT observed during the study (Graphic: Business Wire)

The following chart depicts the mean aPTT observed during the study (Graphic: Business Wire)

http://www.businesswire.com/multimedia/home/20091027005453/en/1871415/PolyMedix-Completes-Successful-Phase-1B-Clinical-Study

View and Share Logo

Share

Email

All News | News with Multimedia > News Release: PolyMedix Completes Successful Phase 1B Clinica...